| Year |
Citation |
Score |
| 2013 |
Apland JP, Aroniadou-Anderjaska V, Figueiredo TH, Green CE, Swezey R, Yang C, Qashu F, Braga MF. Efficacy of the GluK1/AMPA receptor antagonist LY293558 against seizures and neuropathology in a soman-exposure model without pretreatment and its pharmacokinetics after intramuscular administration. The Journal of Pharmacology and Experimental Therapeutics. 344: 133-40. PMID 23042954 DOI: 10.1124/Jpet.112.198689 |
0.708 |
|
| 2011 |
Figueiredo TH, Aroniadou-Anderjaska V, Qashu F, Apland JP, Pidoplichko V, Stevens D, Ferrara TM, Braga MF. Neuroprotective efficacy of caramiphen against soman and mechanisms of its action. British Journal of Pharmacology. 164: 1495-505. PMID 21486285 DOI: 10.1111/J.1476-5381.2011.01427.X |
0.729 |
|
| 2011 |
Williams LR, Aroniadou-Anderjaska V, Qashu F, Finne H, Pidoplichko V, Bannon DI, Braga MF. RDX binds to the GABA(A) receptor-convulsant site and blocks GABA(A) receptor-mediated currents in the amygdala: a mechanism for RDX-induced seizures. Environmental Health Perspectives. 119: 357-63. PMID 21362589 DOI: 10.1289/Ehp.1002588 |
0.707 |
|
| 2011 |
Figueiredo TH, Qashu F, Apland JP, Aroniadou-Anderjaska V, Souza AP, Braga MF. The GluK1 (GluR5) Kainate/{alpha}-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor antagonist LY293558 reduces soman-induced seizures and neuropathology. The Journal of Pharmacology and Experimental Therapeutics. 336: 303-12. PMID 20962029 DOI: 10.1124/Jpet.110.171835 |
0.7 |
|
| 2011 |
Figueiredo TH, Aroniadou-Anderjaska V, Qashu F, Apland JP, Souza AP, Braga MFM. Efficacy of Topiramate Against Soman Intoxication: Attenuation of Seizures Without Neuroprotection American Journal of Neuroprotection and Neuroregeneration. 3: 59-65. DOI: 10.1166/Ajnn.2011.1026 |
0.544 |
|
| 2010 |
Apland JP, Figueiredo TH, Qashu F, Aroniadou-Anderjaska V, Souza AP, Braga MF. Higher susceptibility of the ventral versus the dorsal hippocampus and the posteroventral versus anterodorsal amygdala to soman-induced neuropathology. Neurotoxicology. 31: 485-92. PMID 20570628 DOI: 10.1016/J.Neuro.2010.05.014 |
0.68 |
|
| 2010 |
Qashu F, Figueiredo TH, Aroniadou-Anderjaska V, Apland JP, Braga MF. Diazepam administration after prolonged status epilepticus reduces neurodegeneration in the amygdala but not in the hippocampus during epileptogenesis. Amino Acids. 38: 189-97. PMID 19127342 DOI: 10.1007/S00726-008-0227-2 |
0.723 |
|
| 2009 |
Aroniadou-Anderjaska V, Figueiredo TH, Apland JP, Qashu F, Braga MF. Primary brain targets of nerve agents: the role of the amygdala in comparison to the hippocampus. Neurotoxicology. 30: 772-6. PMID 19591865 DOI: 10.1016/J.Neuro.2009.06.011 |
0.719 |
|
| 2009 |
Fritsch B, Qashu F, Figueiredo TH, Aroniadou-Anderjaska V, Rogawski MA, Braga MF. Pathological alterations in GABAergic interneurons and reduced tonic inhibition in the basolateral amygdala during epileptogenesis. Neuroscience. 163: 415-29. PMID 19540312 DOI: 10.1016/J.Neuroscience.2009.06.034 |
0.727 |
|
| 2008 |
Aroniadou-Anderjaska V, Fritsch B, Qashu F, Braga MF. Pathology and pathophysiology of the amygdala in epileptogenesis and epilepsy. Epilepsy Research. 78: 102-16. PMID 18226499 DOI: 10.1016/J.Eplepsyres.2007.11.011 |
0.703 |
|
| 2007 |
Aroniadou-Anderjaska V, Qashu F, Braga MF. Mechanisms regulating GABAergic inhibitory transmission in the basolateral amygdala: implications for epilepsy and anxiety disorders. Amino Acids. 32: 305-15. PMID 17048126 DOI: 10.1007/S00726-006-0415-X |
0.679 |
|
| Show low-probability matches. |